Mallinckrodt Unveils $1.6 Billion Opioid Deal — And Generic Stocks PopInvestors Business Daily • 02/25/20
Mallinckrodt Rips Higher After Company Confirms $1.6B Opioid Litigation SettlementBenzinga • 02/25/20
Mallinckrodt's stock bounces after opioid-related settlement deal, earnings that beat expectationsMarket Watch • 02/25/20
Mallinckrodt's stock suffering record selloff after WSJ report of talks with creditorsMarket Watch • 02/24/20
Will Mallinckrodt (MNK) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 02/06/20
Mallinckrodt's stocks soars on heavy volume toward near-40% gain this week after comments at broker conferenceMarket Watch • 01/15/20
Mallinckrodt (MNK) Up 28.5% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/05/19